NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

9 hedge funds and large institutions have $174K invested in Northwest Biotherapeutics, Inc. Common stock in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.51K
2
+$345

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MSAM
1
Moloney Securities Asset Management
Missouri
$120K
VWA
2
VSM Wealth Advisory
Maryland
$15.7K
OCG
3
Opus Capital Group
Ohio
$14K
EFG
4
Ethos Financial Group
Pennsylvania
$12.6K
WJWM
5
Williams Jones Wealth Management
New York
$6.48K
KA
6
KLCM Advisors
Wisconsin
$2.4K
AMG
7
Advisors Management Group
Wisconsin
$2K